Ganga Pharma. Stock Price Analysis and Quick Research Report. Is Ganga Pharma. an attractive stock to invest in?
Stock investing requires careful analysis of financial data to determine a company's true net worth. This is generally done by examining the company's profit and loss account, balance sheet and cash flow statement, which can be time-consuming and cumbersome.
Examining a company's financial ratios is an easier way to determine its performance, which can help to make sense of the overwhelming amount of information in its financial statements.
Here are a few indispensable ratios that should be a part of every investor’s research process, or, in simpler words, how to analyse Ganga Pharma..
-
PE ratio: Price to Earnings ratio, which indicates how much an investor is willing to pay for a share for every rupee of earnings. A general rule of thumb is that shares trading at a low P/E are undervalued (it depends on other factors too). Ganga Pharma. has a PE ratio of 110.689916603488 which is high and comparatively overvalued.
-
Return on Assets (ROA): Return on Assets measures how effectively a company can earn a return on its investment in assets. In other words, ROA shows how efficiently a company can convert the money used to purchase assets into net income or profits. Ganga Pharma. has ROA of 0.5606% which is a bad sign for future performance. (Higher values are always desirable.)
-
Current ratio: The current ratio measures a company's ability to pay its short-term liabilities with its short-term assets. A higher current ratio is desirable so that the company could be stable to unexpected bumps in business and economy. Ganga Pharma. has a Current ratio of 4.8101.
-
Return on equity: ROE measures the ability of a firm to generate profits from its shareholders' investments in the company. In other words, the return on equity ratio shows how much profit each rupee of common stockholders’ equity generates. Ganga Pharma. has a ROE of 0.7847%. (Higher is better)
-
Debt to equity ratio: It is a good metric to check out the capital structure along with its performance. Ganga Pharma. has a Debt to Equity ratio of 0.2112 which means that the company has low proportion of debt in its capital.
-
Sales growth: Ganga Pharma. has reported revenue growth of 5.7782% which is poor in relation to its growth and performance.
-
Operating Margin: This will tell you about the operational efficiency of the company. The operating margin of Ganga Pharma. for the current financial year is 2.10850518883667%.
-
Dividend Yield: It tells us how much dividend we will receive in relation to the price of the stock. The current year dividend for Ganga Pharma. is Rs 0 and the yield is 0%.
-
Earnings Per Share: It tells us how much profit is allocated to to each outstanding share of a common stock. The latest EPS of Ganga Pharma. is Rs 0.1319. The higher the EPS, the better it is for investors.
One can find all the Financial Ratios of Ganga Pharma. in Ticker for free. Also, one can get the intrinsic value of Ganga Pharma. by using Valuation Calculators, which are available with a Finology ONE subscription.
Ganga Pharma. FAQs
Q1. What is Ganga Pharma. share price today?
Ans: The current share price of Ganga Pharma. is Rs 14.6.
Q2. What is the market capitalisation of Ganga Pharma.?
Ans: Ganga Pharma. has a market capitalisation of Rs 8.63079 Cr., calculated based on its latest share price.
Q3. What are the P/E and P/B ratios of Ganga Pharma.?
Ans: The PE ratio of Ganga Pharma. is 110.689916603488 and the P/B ratio of Ganga Pharma. is 1.08750707624467, showing how the stock is valued against its earnings and book value.
Q4. What is the 52-week high and low of Ganga Pharma. share?
Ans: The 52-week high share price of Ganga Pharma. is Rs 19.57, and the 52-week low share price of Ganga Pharma. is Rs 9.25.
Q5. Does Ganga Pharma. pay dividends?
Ans: Currently, Ganga Pharma. does not pay dividends. Dividend yield of Ganga Pharma. is around 0%.
Q6. What are the face value and book value of Ganga Pharma. shares?
Ans: The face value of Ganga Pharma. shares is Rs 10, while the book value per share of Ganga Pharma. is around Rs 13.4252. Face value is the nominal value set by the company, whereas book value reflects its accounting worth.
Q7. What is the debt of Ganga Pharma.?
Ans: Ganga Pharma. has a total debt of Rs 1.35801 Cr., which affects investor sentiment and financial stability.
Q8. What are the ROE and ROCE of Ganga Pharma.?
Ans: The ROE of Ganga Pharma. is 0.7847% and ROCE of Ganga Pharma. is 3.1607%. ROE shows how efficiently the company is generating profit from shareholders’ equity, while the ROCE is reflects how efficiently the company uses its capital to generate returns.
Q9. Is Ganga Pharma. a good buy for the long term?
Ans: The Ganga Pharma. long-term outlook depends on debt levels, earnings growth, and sector trends. If it sustains profits and manages debt well, it may be considered for long-term investment.
Q10. Is Ganga Pharma. undervalued or overvalued?
Ans: Based on valuation ratios like P/E, P/B, and EV/EBITDA, one can analyse whether the Ganga Pharma. appears undervalued or overvalued at current levels. You can check detailed valuation metrics and peer comparisons on Finology Ticker.
Q11. How to check Ganga Pharma.’s financials?
Ans: You can review Ganga Pharma.’s financial statements - including balance sheet, income statement, and quarterly results - on Finology Ticker.